Tetra Stock

tetradiscovery.comHealthcareFounded: 2010Funding to Date: $40.04MM

Tetra Therapeutics is clinical stage biotechnology company developing medicines for Alzheimer's Disease, Fragile X syndrome, Traumatic Brain Injury, major depression and schizophrenia.

Register for Details

For more details on financing and valuation for Tetra, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Tetra.

Register Today

Team

Management Team

Joseph Collard
Board Member & Chief Business Officer
Harvey Elgersma
Chief Financial Officer
Richard Nugent Ph.D
Director of Chemistry
Mark Gurney Ph.D
Founder, Chief Executive Officer & Chairman
Scott Reines Ph.D
Chief Medical Officer

Board Members

Donald Parfet
Biosciences Research and Commercialization Center
Lance Stewart Ph.D
Paul D'Amato
Grand Angels
Douglas Morton Ph.D
Mark Gurney Ph.D
Rob Jandernoa
Akira Kato Ph.D
Joseph Collard

Other companies like Tetra in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
 
 
Sector
Last Round Est. Valuation
$317.32MM
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$1.59B
Sector
Last Round Est. Valuation
$4.26B
Sector